COMBINEDBrain retweeted
You'll know by now that we've officially launched #60SecondsofRARE.
To get involved, email rpender@rarerevolutionmagazine, and you'll receive four questions, including video guidelines
Then, film yourself answering the four questions, and that's it!
COMBINEDBrain retweeted
#ShineYourSearchlight✨ Do you live in the USA? Make sure your genetic variant is part of the @SimonsSearchlight biorepository! Your blood sample can help in creating future therapies and treatments. Contact [email protected] to learn more. #OCNDS #CSNK2A1
COMBINEDBrain retweeted
Want to learn how to get involved on a state level? Join @EveryLifeOrg for their Apr. 12 webinar on Building Relationships with State Decision Makers. Learn best practices and hear directly from advocates who are taking action in their states.
go.globalgenes.org/everylife…
COMBINEDBrain retweeted
NORD's #LivingRareForum is just one month away on Saturday, May 6, 2023!
Join hundreds of patients, families, & #RareDisease community members in Washington, DC for a day full of education, inspiration, & celebration of NORD's 40th anniversary.
Register: bit.ly/3Lu3oOZ
COMBINEDBrain retweeted
There are four active clinical trials for Angelman syndrome! New site locations have recently been added to the ongoing studies, and additionally, a new observational study was just announced.
🔬 Check out more info about these clinical trials:
buff.ly/3nCm8VB
Great news, & great exposure for Angelman.
📰 A new article in the Wall Street Journal profiles FAST and its innovative approach to make cutting-edge clinical treatments available to everyone who needs them.
Read the article here:
buff.ly/3KAwi2d

ALT The Wall Street Journal: These Drugs Are So Futuristic That Doctors Need New Training. Next-generation treatments on the way for once-incurable diseases can be complicated to test and administer; ‘if we can’t get it to these patients, the science is lost’, with Dr. Berry-Kravis administering a therapeutic to a patient
🧵
NHGRI’s Clinical Director @BenjaminSolomo2 first fell in love with genetics and genomics in the 7th grade. In medical school, he admired geneticists who were determined to help diagnose patients.
COMBINEDBrain retweeted
🏛️ This work falls within FAST’s Pillar 4 - Accelerating and Preparing for Clinical Trials in our Roadmap to a Cure 2.0, and is particularly exciting for our community right now, given the multiple ongoing and emerging clinical trials.
COMBINEDBrain retweeted
A new publication from Dr. Anne Anderson’s lab at Baylor College of Medicine evaluates EEG as a tool, or biomarker, to objectively measure therapeutic efficacy in Angelman syndrome.
Read more about the publication's findings:
buff.ly/3KaM6r6
Bohring-Opitz Syndrom is one of three ASXL conditions: ASXL1 ASXL2 and ASXL3
The features and abilities of people with Bohring-Opitz Syndrome varies greatly. We do not yet know why there is broad variation in features and abilities. 1/
Watch here to learn more about ASXL1 on Today is Bohring-Opitz Awareness Day. Watch here to learn more
youtu.be/7ntCz0GuYXk
youtu.be/zQjNsXg7FwYICYMI, replay this webinar on our biobank & partnership with Syngap Research fund for SYNGAP1. Biorepositories--banks of samples--are a powerful tool for medical research.
Information on the albuterol shortage, for patients whose disease burden includes asthma. lung.org/blog/albuterol-shor…
COMBINEDBrain retweeted
The *first* global #census for #STXBP1 is published! 903 patients from 45 countries!
We know there are more STX'ers out there. Check out the news article and be counted!
stxbp1disorders.org/news/stx…
#STXBP1GlobalConnect @stxbp1
COMBINEDBrain retweeted
Here is the link for #TopDownloadedArticle for ASXL3-related disorder and largest natural history on this common disorder to date. Further work on an even bigger cohort and more follow up data ongoing!
onlinelibrary.wiley.com/doi/… @ShefUni_OncMet @SheffChildrens @arrefoundation

















